PHARMACEUTICAL PREPARATION IMPROVING PERMEABILITY THROUGH MUCOSA

    公开(公告)号:JPH1067686A

    公开(公告)日:1998-03-10

    申请号:JP20442197

    申请日:1997-07-30

    Applicant: BASF AG

    Abstract: PROBLEM TO BE SOLVED: To prepare pharmaceutical preparation having no danger of a cytolytic or other toxic side effect and capable of eliminating an technical defect of use of a high viscosity material, etc., and improving permeability through an epithelial cell by including a (meth)acrylic acid-maleic acid copolymer. SOLUTION: This pharmaceutical preparation is the one for improving permeability through an epithelial cell and includes a (meth)acrylic acid-maleic acid copolymer e.g. the one composed of (A) 10-90mol% (meth)acrylic acid or its salt or anhydride, (B) 90-10mol% maleic acid or its salt or anhydride and (C) 0-40mol% monomer without components A and B [e.g. vinylsulfonic acid, a (meth)acrylic ester of a 2-6C hydroxyalkyl or a (meth)acrylic acid ester of 1-40C alkyl] and having 5,000-500,000, especially 10,000-300,000 weight average molecular weight}. The preparation is administered in a shape of a tablet, a granule, a suppository, an ointment, a solution, etc., by an oral, hypoglottis, oral cavity, pulmonary artery or pernasal administration, or an administration through ocular-mucous membrance.

    Binder for high strength tablet, comprising finely crushed vinyl lactam polymer as base material, and its production and use
    2.
    发明专利
    Binder for high strength tablet, comprising finely crushed vinyl lactam polymer as base material, and its production and use 有权
    用于高强度片材的粘合剂,包括作为基材的精美的聚乙烯醇缩丁醛聚合物及其生产和使用

    公开(公告)号:JP2006316266A

    公开(公告)日:2006-11-24

    申请号:JP2006114546

    申请日:2006-04-18

    CPC classification number: A61K47/32 A61K9/2027 C08F226/06 C08F226/10

    Abstract: PROBLEM TO BE SOLVED: To provide a powder shape finely crushed binder useful on the production of tablets, and to provide a method for producing the same. SOLUTION: This powder shape finely crushed binder comprises a vinyl lactam polymer, having an average particle size of ≤35 μm and an apparent density of ≤0.2 g/ml. The method for producing the binder comprises spraying a vinyl lactam polymer aqueous solution having a solid content of 1 to 35 wt.% with a single liquid nozzle under a pressure of ≥8 MPa or with a double liquid nozzle under a pressure of ≥0.2 MPa, and then drying the sprayed product with a hot gas flow. COPYRIGHT: (C)2007,JPO&INPIT

    Abstract translation: 待解决的问题:提供可用于制备片剂的粉末形状的细粉碎粘合剂,并提供其制备方法。 解决方案:该粉末形状的细粉碎粘合剂包括平均粒径≤35μm,表观密度≤0.2g/ ml的乙烯基内酰胺聚合物。 制造粘合剂的方法包括在≥8MPa的压力下用单液体喷嘴或在≥0.2MPa的压力下用双液体喷嘴喷雾固体含量为1〜35重量%的乙烯基内酰胺聚合物水溶液 ,然后用热气流干燥喷雾产物。 版权所有(C)2007,JPO&INPIT

    RAPIDLY DISPERSIBLE, FINE-GRAINED, SEPARATION-RESISTANT PULVERULENT FILM COATING AGENT, BASED ON POLYVINYL ALCOHOL-POLYETHER GRAFT COPOLYMERS AND CHARACTERISED BY A PARTICULAR PHYSICAL STABILITY AND A LOW DEGREE OF ROUGHNESS
    5.
    发明申请
    RAPIDLY DISPERSIBLE, FINE-GRAINED, SEPARATION-RESISTANT PULVERULENT FILM COATING AGENT, BASED ON POLYVINYL ALCOHOL-POLYETHER GRAFT COPOLYMERS AND CHARACTERISED BY A PARTICULAR PHYSICAL STABILITY AND A LOW DEGREE OF ROUGHNESS 审中-公开
    SCHNELLDISPERGIERBARES,佳作,而不是隔离,往往粉未状薄膜包衣剂基于具特殊的物理稳定性和低粗糙度聚乙烯醇 - 聚醚接枝共聚物

    公开(公告)号:WO2006002808A3

    公开(公告)日:2006-09-14

    申请号:PCT/EP2005006718

    申请日:2005-06-22

    CPC classification number: A61K9/2853 A61K9/284

    Abstract: The invention relates to a rapidly dispersible, fine-grained, separation-resistant film coating agent for coating pharmaceutical dosage forms, consisting of a) 40 - 90 wt % of a polyvinyl alcohol-polyether graft copolymer (component A), b) 1 - 20 wt. % of a polyvinyl pyrrolidone or a vinyl pyrrolidone-vinyl acetate copolymer with a K-value of between 10 and 100 (component B), c) 10 - 60 wt. % of an organic or inorganic pigment with an average particle size that is less than 8 µm (component C), d) 0.5 - 15 wt. % of a surfactant with an HLB value that is greater than 10 (component D) and e) 0 - 30 wt % of additional conventional coating constituents (component E). In said agent, the particles of component C are embedded in a coherent polymer matrix and the quantity of components A to E totals 100 wt. %.

    Abstract translation: Schnelldispergierbares,细碎的不偏析趋于粉末包衣组合物用于涂覆药物剂型,包括一个)40 - 90重量聚乙烯醇 - 聚醚接枝共聚物的%(组分A),B)1 - 20重量聚乙烯吡咯烷酮的%或 具有10至100(B成分)c)中的K值从10至60重量%0.5具有8微米以下(C成分的平均粒径的有机或无机颜料情况)d)由乙烯基吡咯烷酮 - 乙酸乙烯酯共聚物,以15%的 .-具有HLB值大于10(D成分),和e)0-30重量其它常规包衣成分(分量e的百分比),其中组分C的颗粒被嵌入在一个连贯聚合物基质中的表面活性剂的%,其中 组分A至E的量为100添加重量%。

    METHOD FOR THE PRODUCTION OF SOFT CAPSULE ENVELOPES BASED ON POLYVINYL ALCOHOL-POLYETHYLENE GLYCOL GRAFT POLYMERS
    6.
    发明申请
    METHOD FOR THE PRODUCTION OF SOFT CAPSULE ENVELOPES BASED ON POLYVINYL ALCOHOL-POLYETHYLENE GLYCOL GRAFT POLYMERS 审中-公开
    用于生产软胶囊容器基于聚乙烯醇 - 聚乙二醇接枝共聚物

    公开(公告)号:WO2007028758A3

    公开(公告)日:2007-05-10

    申请号:PCT/EP2006065865

    申请日:2006-08-31

    Inventor: KOLTER KARL

    Abstract: Disclosed is a method for producing gelatin-free soft capsule envelopes based on polyvinyl alcohol-polyether graft polymers as enveloping polymers. Said method is characterized in that an aqueous solution containing at least 45 percent by weight of a polymer component which comprises a polyvinyl alcohol-polyether graft polymer or a mixture of polyvinyl alcohol-polyether graft polymers and polyvinyl alcohol is heated, the percentage being in relation to the total weight of the solution, the solution is extruded at a minimum temperature of 70 °C, and the obtained film is solidified by cooling.

    Abstract translation: 一种用于基于无明胶软胶囊壳的制造方法,其特征聚乙烯醇 - 聚醚接枝聚合物作为壳聚合物,加入含有至少45重量%的水溶液中,基于溶液的总重量的聚合物组分,其中所述聚合物组分由聚乙烯醇的 聚醚接枝聚合物或聚乙烯醇 - 聚醚接枝共聚物和聚乙烯醇的混合物加热,将溶液在至少70℃的温度下挤出并凝固所造成的冷却薄膜。

    PHARMACEUTICAL FORMULATION FOR PRODUCING RAPIDLY DISINTEGRATING TABLETS
    8.
    发明申请
    PHARMACEUTICAL FORMULATION FOR PRODUCING RAPIDLY DISINTEGRATING TABLETS 审中-公开
    药物制剂FOR FAST崩解片剂的制造

    公开(公告)号:WO2007071581A3

    公开(公告)日:2008-01-10

    申请号:PCT/EP2006069515

    申请日:2006-12-11

    CPC classification number: A61K9/0056 A61K9/2018

    Abstract: The invention relates to a pharmaceutical formulation in the form of agglomerates containing a) 60 - 97 % by weight of sugar or sugar alcohols, b) 1 - 25 % by weight of cross-linked polyvinylpyrrolidone, c) 1 - 15 % by weight of water-insoluble, film-forming polymers, d) 0 - 15 % by weight of water-soluble polymers, and e) 0 - 15 % by weight of other pharmaceutically suitable adjuvants, the sum of components a) to e) adding up to 100 % by weight.

    Abstract translation: 在含有糖或糖醇的)60-97重量%的聚集体形式的药物制剂,b)中1 - 25重量%的交联聚乙烯吡咯烷酮,C)1 - 15重量%的水不溶性,成膜聚合物d)0 - 15 重量的水溶性聚合物的.-%,和e)0 - 15重量%的其它药学上常用的赋形剂,其中组分的总和a)至e)为100重量%(重量)。

Patent Agency Ranking